Suppr超能文献

阿尔茨海默病淀粉样蛋白的新型前体具有蛋白酶抑制活性。

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

作者信息

Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H

机构信息

Life Science Research Laboratories, Asahi Chemical Industry Co. Ltd., Shizuoka, Japan.

出版信息

Nature. 1988 Feb 11;331(6156):530-2. doi: 10.1038/331530a0.

Abstract

Alzheimer's disease is characterized by cerebral deposits of amyloid beta-protein (AP) as senile plaque core and vascular amyloid, and a complementary DNA encoding a precursor of this protein (APP) has been cloned from human brain. From a cDNA library of a human glioblastoma cell line, we have isolated a cDNA identical to that previously reported, together with a new cDNA which contains a 225-nucleotide insert. The sequence of the 56 amino acids at the N-terminal of the protein deduced from this insert is highly homologous to the basic trypsin inhibitor family, and the lysate from COS-1 cells transfected with the longer APP cDNA showed an increased inhibition of trypsin activity. Partial sequencing of the genomic DNA encoding APP showed that the 225 nucleotides are located in two exons. At least three messenger RNA species, apparently transcribed from a single APP gene by alternative splicing, were found in human brain. We suggest that protease inhibition by the longer APP(s) could be related to aberrant APP catabolism.

摘要

阿尔茨海默病的特征是大脑中存在作为老年斑核心的β-淀粉样蛋白(AP)沉积物和血管淀粉样蛋白,并且已经从人脑中克隆出编码该蛋白前体(APP)的互补DNA。从人胶质母细胞瘤细胞系的cDNA文库中,我们分离出一个与先前报道的cDNA相同的cDNA,以及一个含有225个核苷酸插入片段的新cDNA。从该插入片段推导的蛋白质N端56个氨基酸的序列与碱性胰蛋白酶抑制剂家族高度同源,用较长的APP cDNA转染的COS-1细胞裂解物对胰蛋白酶活性的抑制作用增强。对编码APP的基因组DNA进行的部分测序表明,这225个核苷酸位于两个外显子中。在人脑中发现了至少三种信使RNA,显然是通过可变剪接从单个APP基因转录而来的。我们认为较长的APP的蛋白酶抑制作用可能与异常的APP分解代谢有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验